ATE339217T1 - Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut - Google Patents

Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut

Info

Publication number
ATE339217T1
ATE339217T1 AT01967094T AT01967094T ATE339217T1 AT E339217 T1 ATE339217 T1 AT E339217T1 AT 01967094 T AT01967094 T AT 01967094T AT 01967094 T AT01967094 T AT 01967094T AT E339217 T1 ATE339217 T1 AT E339217T1
Authority
AT
Austria
Prior art keywords
caseinoglycomacropeptide
inhibiting
adhesion
skin
pathogenic flora
Prior art date
Application number
AT01967094T
Other languages
English (en)
Inventor
Jean-Richard Neeser
Isabelle Auzanneau
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE339217(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE339217T1 publication Critical patent/ATE339217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
AT01967094T 2000-07-14 2001-06-28 Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut ATE339217T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00115274 2000-07-14

Publications (1)

Publication Number Publication Date
ATE339217T1 true ATE339217T1 (de) 2006-10-15

Family

ID=8169257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01967094T ATE339217T1 (de) 2000-07-14 2001-06-28 Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut

Country Status (14)

Country Link
US (1) US20030161850A1 (de)
EP (1) EP1303295B1 (de)
JP (1) JP2004503597A (de)
AR (1) AR029829A1 (de)
AT (1) ATE339217T1 (de)
AU (1) AU2001287560A1 (de)
CA (1) CA2415918C (de)
DE (1) DE60123067T2 (de)
DK (1) DK1303295T3 (de)
ES (1) ES2272535T3 (de)
PE (1) PE20020147A1 (de)
PT (1) PT1303295E (de)
UY (1) UY26835A1 (de)
WO (1) WO2002005839A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
AU2008303849A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic use of peptide YGLF and combination with KVLPVPQ
CA2797658C (en) 2010-04-21 2021-06-08 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7786M (de) * 1968-10-07 1970-03-23
FR8087M (de) * 1968-10-08 1970-07-20
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
DE3049038A1 (de) * 1980-12-24 1982-07-15 Marie 8000 München Hauck Mittel zur bekaempfung von hautkrankheiten
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
CH671879A5 (de) * 1987-02-26 1989-10-13 Nestle Sa
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5166132A (en) * 1989-03-23 1992-11-24 Gordon Arthur L Healing composition employing an enzyme-modified casein
US5681586A (en) * 1989-03-23 1997-10-28 Gordon; Arthur L. Enzyme-modified soy and soy/casein combination healing compositions
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
FR2657525B1 (fr) * 1990-01-26 1994-07-29 Dubois Jacques Produits dermo-cosmetiques nouveaux pour le nettoyage et le soin de la peau et/ou des cheveux.
JPH10500101A (ja) * 1994-05-26 1998-01-06 アボツト・ラボラトリーズ インフルエンザ菌のヒト細胞への付着の阻害
WO1998046240A1 (en) * 1997-04-15 1998-10-22 Advanced Viral Research Corp. Topical treatment of skin diseases and eye afflictions

Also Published As

Publication number Publication date
CA2415918A1 (en) 2002-01-24
DE60123067D1 (de) 2006-10-26
JP2004503597A (ja) 2004-02-05
PE20020147A1 (es) 2002-02-26
AU2001287560A1 (en) 2002-01-30
ES2272535T3 (es) 2007-05-01
PT1303295E (pt) 2007-01-31
EP1303295B1 (de) 2006-09-13
DE60123067T2 (de) 2007-04-12
DK1303295T3 (da) 2007-01-02
WO2002005839A1 (en) 2002-01-24
AR029829A1 (es) 2003-07-16
EP1303295A1 (de) 2003-04-23
CA2415918C (en) 2010-06-01
UY26835A1 (es) 2002-01-31
US20030161850A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DE60032275D1 (de) Verfahren und Zwischenprodukte zur Herstellung von Antikrebsmitteln
DE60017336D1 (de) Zusammensetzung zur Herstellung von Harzen
DE60042116D1 (de) Selektion von ortungseinrichtungen zur positionsbe
DE69920935D1 (de) Vefahren zur verbesserung der süssefreigabe von sucralose
DE60035029D1 (de) Verfahren zur herstellung von furfural
DE60029779D1 (de) Zusammensetzungen zur Herstellung von En-Thiol-Elastomeren
DE69906389T2 (de) Verfahren zur herstellung von citalopram
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60106933D1 (de) Verfahren zur herstellung von citalopram
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
SE9901077D0 (sv) Novel use
ATE232378T1 (de) Reinigungspflaster zur verbesserung des hautzustandes
DE60100858D1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
DE60127538D1 (de) Verfahren zur herstellung von methionin
ATE348626T1 (de) Milchsäurebakterium zur prävention der bauchfellentzündung
DE60033117D1 (de) Verhinderung des Festklebens von Hartkonfekten
ATE339217T1 (de) Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut
DE60135763D1 (de) System zur herstellung von bauholz mit abgerundeten enden
DE60133280D1 (de) Verfahren zur herstellung von citalopram
DE69816021D1 (de) Verbesserungen in bezug auf druckübertrager zur benutzung in der herstellung von verbundwerkstoffkomponenten
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE50001739D1 (de) Parfüm mit möglichkeiten zur änderung der duftnote
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1303295

Country of ref document: EP